Skip to main content

Zymergen Inc.

ZYDelisted Oct 19, 2022
Industry
Services-Commercial Physical & Biological Research
SEC CIK
0001645842

Zymergen Inc. was delisted on Oct 19, 2022; its insiders filed their last Form 4 on Oct 21, 2022; 86 institutions reported holding it in 13F filings for Q3 2022, worth $168.1M in total; ARK Invest was the only superinvestor holding it.

Holders of 5% or more of ZY

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Zymergen Inc., largest stake first. The change is against the holder's previous filing.

No holder currently reports owning 5% or more of Zymergen Inc. on Schedule 13D or 13G.

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

6 Schedule 13D and 13G filings on Zymergen Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on ZY
Filed (ET)FilerFormStakeChangeEvent dateFiling
Oct 21, 2022SB Investment Advisers (UK) Ltd13G/AOld format–––SEC
Feb 14, 2022SB Investment Advisers (UK) Ltd13GOld format–New–SEC
Feb 14, 2022Data Collective II, L.P.13GOld format–New–SEC
Feb 11, 2022True Ventures IV, L.P.13GOld format–New–SEC
Feb 11, 2022GIC Private Ltd13G/AOld format–––SEC
May 5, 2021GIC Private Ltd13GOld format–New–SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Zymergen Inc. shares.

No Form 144 notices for Zymergen Inc. are on file.